We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generics Group Weighs in on Amarin’s ‘Skinny Label’ Lawsuit
Generics Group Weighs in on Amarin’s ‘Skinny Label’ Lawsuit
The Association for Accessible Medicines (AAM) has filed an amicus brief in a federal court in support of Hikma Pharmaceuticals’ generic version of the Amarin Pharmaceuticals heart drug Vascepa.